ReviewFrontiers in ophthalmology2025

Real-world impact of latanoprostene bunod ophthalmic solution 0.024% in glaucoma therapy: a narrative review.

W Daniel Stamer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.